Nanhua Bio Medicine Co Ltd (000504) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanhua Bio Medicine Co Ltd (000504) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.42 Million ≈ $3.28 Million USD) by net assets (CN¥362.66 Million ≈ $53.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Nanhua Bio Medicine Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Nanhua Bio Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Nanhua Bio Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Nanhua Bio Medicine Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Nanhua Bio Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanhua Bio Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XinJiang Beiken Energy Engineering Stock Co Ltd
SHE:002828
|
0.068x |
|
Guangxi Fenglin Wood Industry Group Co Ltd
SHG:601996
|
0.028x |
|
Ganso Co Ltd
SHG:603886
|
-0.099x |
|
Berjaya Corporation Bhd
KLSE:3395
|
-0.018x |
|
Mirbud SA
WAR:MRB
|
0.000x |
|
Agro Tech Foods Limited
NSE:ATFL
|
0.022x |
|
Nanjing Shenghang Shipping Co Ltd
SHE:001205
|
0.034x |
|
Hanyang ENG Co. Ltd
KQ:045100
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Nanhua Bio Medicine Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Nanhua Bio Medicine Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Nanhua Bio Medicine Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥357.51 Million ≈ $52.31 Million |
CN¥-115.74 Million ≈ $-16.94 Million |
-0.324x | -2004.44% |
| 2024-12-31 | CN¥282.00 Million ≈ $41.27 Million |
CN¥4.79 Million ≈ $701.45K |
0.017x | -85.72% |
| 2023-12-31 | CN¥304.67 Million ≈ $44.58 Million |
CN¥36.28 Million ≈ $5.31 Million |
0.119x | -94.28% |
| 2022-12-31 | CN¥79.88 Million ≈ $11.69 Million |
CN¥166.38 Million ≈ $24.35 Million |
2.083x | +114.54% |
| 2021-12-31 | CN¥110.32 Million ≈ $16.14 Million |
CN¥107.10 Million ≈ $15.67 Million |
0.971x | +163.00% |
| 2020-12-31 | CN¥134.48 Million ≈ $19.68 Million |
CN¥-207.22 Million ≈ $-30.32 Million |
-1.541x | -1314.43% |
| 2019-12-31 | CN¥114.46 Million ≈ $16.75 Million |
CN¥14.52 Million ≈ $2.13 Million |
0.127x | +190.02% |
| 2018-12-31 | CN¥107.75 Million ≈ $15.77 Million |
CN¥-15.19 Million ≈ $-2.22 Million |
-0.141x | +61.81% |
| 2017-12-31 | CN¥128.43 Million ≈ $18.79 Million |
CN¥-47.40 Million ≈ $-6.94 Million |
-0.369x | -101.57% |
| 2016-12-31 | CN¥79.76 Million ≈ $11.67 Million |
CN¥-14.60 Million ≈ $-2.14 Million |
-0.183x | -115.47% |
| 2015-12-31 | CN¥-14.51 Million ≈ $-2.12 Million |
CN¥-17.17 Million ≈ $-2.51 Million |
1.184x | +125.51% |
| 2014-12-31 | CN¥7.03 Million ≈ $1.03 Million |
CN¥-32.60 Million ≈ $-4.77 Million |
-4.639x | -41.07% |
| 2013-12-31 | CN¥3.57 Million ≈ $522.49K |
CN¥-11.74 Million ≈ $-1.72 Million |
-3.289x | -1699.99% |
| 2012-12-31 | CN¥-20.80 Million ≈ $-3.04 Million |
CN¥-4.28 Million ≈ $-625.68K |
0.206x | +958.05% |
| 2011-12-31 | CN¥130.38 Million ≈ $19.08 Million |
CN¥-3.12 Million ≈ $-457.01K |
-0.024x | +93.96% |
| 2010-12-31 | CN¥161.13 Million ≈ $23.58 Million |
CN¥-63.95 Million ≈ $-9.36 Million |
-0.397x | -195.00% |
| 2009-12-31 | CN¥144.30 Million ≈ $21.12 Million |
CN¥60.28 Million ≈ $8.82 Million |
0.418x | +725.04% |
| 2008-12-31 | CN¥278.16 Million ≈ $40.70 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.067x | -425.61% |
| 2007-12-31 | CN¥449.00 Million ≈ $65.70 Million |
CN¥9.22 Million ≈ $1.35 Million |
0.021x | +1169.29% |
| 2006-12-31 | CN¥443.78 Million ≈ $64.94 Million |
CN¥717.62K ≈ $105.01K |
0.002x | -93.67% |
| 2005-12-31 | CN¥445.86 Million ≈ $65.24 Million |
CN¥11.40 Million ≈ $1.67 Million |
0.026x | -14.73% |
| 2004-12-31 | CN¥443.86 Million ≈ $64.95 Million |
CN¥13.31 Million ≈ $1.95 Million |
0.030x | -77.23% |
| 2003-12-31 | CN¥423.50 Million ≈ $61.97 Million |
CN¥55.75 Million ≈ $8.16 Million |
0.132x | +221.97% |
| 2002-12-31 | CN¥387.30 Million ≈ $56.67 Million |
CN¥15.83 Million ≈ $2.32 Million |
0.041x | -61.50% |
| 2001-12-31 | CN¥322.29 Million ≈ $47.16 Million |
CN¥34.22 Million ≈ $5.01 Million |
0.106x | +1318.35% |
| 2000-12-31 | CN¥385.75 Million ≈ $56.45 Million |
CN¥-3.36 Million ≈ $-491.98K |
-0.009x | +21.76% |
| 1999-12-31 | CN¥173.52 Million ≈ $25.39 Million |
CN¥-1.93 Million ≈ $-282.86K |
-0.011x | -218.50% |
| 1998-12-31 | CN¥352.69 Million ≈ $51.61 Million |
CN¥3.32 Million ≈ $485.17K |
0.009x | -- |
About Nanhua Bio Medicine Co Ltd
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment engages in the provision of stem cell, immune cell storage and technical services, and medical device trade. The Energy Saving and Environmental Protection segment is involved in the external energy management … Read more